According to molecular characteristics, BC could be divided into at least four subtypes: luminal A, luminal B, human epidermal growth factor receptor 2 positive (HER2+), and triple-negative BC (TNBC) [3]. This evidence concerns the gene ERBB2 and breast cancer.